Earth Life Sciences Inc
Change company Symbol lookup
Select an option...
CLTS Earth Life Sciences Inc
CYBN Cybin Inc
LEN.B Lennar Corp
STLD Steel Dynamics Inc
GOEVW Canoo Equity Warrant Exp 21st Dec 2025 *W EXP 12/21/2025
GNBT Generex Biotechnology Corp
MFA MFA Financial Inc
GOOG Alphabet Inc
ADILW Adial Pharmaceuticals Equity Warrants Exp 31 July 2023 *W EXP 07/31/2023
MBDC Massachusetts Business Development Corp
Go


Based in Canada
Company profile

Earth Life Sciences Inc. is a healthcare company. The Company through its subsidiary, VIVA Health HK Limited (Viva Health), is engaged in providing health services primarily in the United States. Viva Health is focused on building a platform in the United States, which optimizes the functions of health care staff training management, health care service management and quality control, and providing a range of services in the United States, and particularly for aging Asian families. Through its artificial intelligence (AI), the Company seeks to assist in the customization and implementation of a software platform, which facilitates the delivery of onsite lifestyle services and well-being to families across the United States under the banner of VIVA USA. The Company through, Anhutong Healthcare Platform, provides a one stop smart healthcare service brand in the healthcare industry.

Closing Price
$0.0065
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Average)
Volume:
42,000

10-day average volume:
67,431
42,000

Pfizer Inc. Stock Rises Wednesday, Still Underperforms Market

5:14 pm ET August 10, 2022 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Pfizer Inc. (PFE) inched 0.34% higher to $49.95 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 2.13% to 4,210.24 and the Dow Jones Industrial Average rising 1.63% to 33,309.51. This was the stock's third consecutive day of gains. Pfizer Inc. closed $11.76 below its 52-week high ($61.71), which the company achieved on December 20th.

The stock outperformed some of its competitors Wednesday, as Johnson & Johnson (JNJ) rose 0.29% to $170.67, Merck & Co. Inc. (MRK) fell 0.37% to $89.19, and Novartis AG ADR (NOVN.EB) rose 0.32% to $87.43. Trading volume (17.3 M) remained 2.5 million below its 50-day average volume of 19.9 M.

Data source: Dow Jones Market Data, FactSet. Data compiled August 10, 2022.

	

(END) Dow Jones Newswires

August 10, 2022 17:14 ET (21:14 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.